Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Yuqin Song"'
Autor:
Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Chris Wang, Laura Ma, Su Yang, Zisong Zhou, Yun Qin, Yuqin Song, Jun Zhu
Publikováno v:
Cytotherapy. 25:521-529
Autor:
Zhijuan Lin, Jie Zha, Shuhua Yi, Zhifeng Li, Lingyan Ping, Xiaohua He, Liyuan Fan, Haifeng Yu, Zhong Zheng, Wei Xu, Feili Chen, Ying Xie, Biyun Chen, Huilai Zhang, Li Wang, Kaiyang Ding, Wenyu Li, Haiyan Yang, Weili Zhao, Lugui Qiu, Zhiming Li, Yuqin Song, Bing Xu
Publikováno v:
Clinical and Translational Oncology. 25:1821-1829
Autor:
Jie Che, Zhaoran Wang, Yuqin Song, Hongxia Guan, Min Yuan, Xia Chen, Xiaofei Zhao, Yong Xiao, Yunfei Zhang, Dan Sha, Chao Wang, Jie Feng, Juan Li
Publikováno v:
Microbiology Spectrum. 11
IMI carbapenemases have been detected in clinical isolates of many bacterial species with systemic infection and cause a further burden on clinical treatment in China, but their source and distribution are still unclear. The study systematically inve
Autor:
Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael L. Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Publikováno v:
Blood. 140:6501-6503
Autor:
Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Alex Tian, Tony Huang, Zisong Zhou, Meilin Ma, Su Yang, Yun Qin, Jun Zhu
Publikováno v:
Blood. 140:10329-10331
Autor:
Yuqin Song, Ning Ding, Dok Hyun Yoon, John C. Reneau, Ryan A. Wilcox, Won Seog Kim, Youn H. Kim, Michael S. Khodadoust, Tatyana A. Feldman, Costas K. Yannakou, Pratyush Giri, Jonathan E Brammer, Lih-Yun Hsu, Hongwei Yuan, Erik Verner, Suresh Mahabhashyam, Richard A. Miller
Publikováno v:
Blood. 140:8857-8859
Autor:
Yuqin Song, Herve Tilly, Shinya Rai, Huilai Zhang, Jie Jin, Hideki Goto, Yasuhito Terui, Ho-Jin Shin, Won Seog S Kim, Junning Cao, Jifeng Feng, Hyeon-Seok Eom, Tae Min Kim, Xavier Cheng-Hong Tsai, Jyh-Pyng Gau, Hideo Koh, Liling Zhang, Yongping Song, Yu Yang, Wei Li, He Huang, Kiyoshi Ando, Jeff P. Sharman, Laurie H Sehn, Lilian Bu, Xin Wang, Yanwen Jiang, Jamie Hirata, Calvin Lee, Jun Zhu, Koji Izutsu
Publikováno v:
Blood.
In the phase 3 POLARIX study (NCT03274492), polatuzumab vedotin combined with rituximab plus cyclophosphamide, doxorubicin and prednisone (Pola-R-CHP) significantly improved progression-free survival (PFS) compared with rituximab plus cyclophosphamid
Autor:
Fei Qi, Wenyuan Zhou, Yan Xie, Yan Sun, Meng Wu, Yue Chai, Bo Chen, Ningjing Lin, Weiping Liu, Ning Ding, Yexiong Li, Mei Dong, Yuqin Song, Jun Zhu
Publikováno v:
Aging. 14(21)
We aimed to assess the association between induction chemotherapy (CT) response and survivals and to explore an induction CT response-adapted treatment strategy for localized extranodal NK/T-cell lymphoma (NKTCL) receiving first-line sequential CT an
Publikováno v:
Aging (Albany NY)
Typically, peripheral T-cell lymphoma (PTCLs) prognosis is estimated using overall survival before treatment. However, these estimates cannot show how prognosis evolves with the changing hazard rate over time. Patients (n = 650) with newly diagnosed
Autor:
Yuqin Song, Won-Seog Kim, Dok-Hyun Yoon, Haiyan Yang, Junning Cao, Dongmei Ji, Youngil Koh, Hongmei Jing, Hyeon-Seok Eom, Jae-Yong Kwak, Won-Sik Lee, Jong-Seok Lee, Ho-Jin Shin, Jie Jin, Mei Wang, Jingrun Li, Jun Zhu
Publikováno v:
Blood. 140:6545-6546